RE: Government considers annual health checks and OH subsidies8 Mar 2023 08:59
Now the dust has settled and looking at the latest broker report below, TLY now on a p/e of just 5 and forecast is still for continued growth as detailed below. TLY still a healthy cash balance of £5m and still maintaining dividend and still seeking out new contracts. At just 18/19p the dramatic drop appears out of sync imo and why I added further at 19p and await a re-rating higher when markets settle
broker report 2.3.23
TLY is facing similar challenges to the NHS as it seeks to provide essential healthcare support. This includes cost inflation, service and schedule pressure and strike action .....Our forecasts assume FY23E revenue of £140.8m which suggests 11% growth y/y.
while revenues for the year ending March 2023 are expected to be broadly in line with expectations, EBITDA will fall
short of forecasts while still being marginally higher than FY22. The Board cites workforce shortages, inflation and increased usage of agency staff and strikes as factors inflating the cost base, all of which are similarly impacting the NHS itself. The Group and management team are nevertheless resilient and we anticipate a continuation of growth in the year to March 2024
In spite of the challenges surrounding delivery of urgent care services, the Group’s insourcing and outsourcing services have
seen strong demand with a doubling of revenue in the year. In addition, the new contract awarded in January 2023 for the delivery of NHS 111 resilience support which went live in February 23 will deliver additional organic revenue growth.
Full year EBITDA expectations of an anticipated £6.3m with Year end cash levels expected to be approximately £5.5m. The Company expects to maintain its dividend in line with previous expectations
The Board remains confident in the prospects for the Company and we expect continued growth and opportunities for expansion going forward. While these headwinds are creating challenges for management, we remain of the view that the Group will be able to mitigate these and continue to deliver robust growth